🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Canada / NCT03378856
Recruiting Observational

Evaluation of Technological Innovation in Radiotherapy

NCT03378856 · tracked via the Priya Life Science Canada tracker
Phase
Observational
Started
2017-11-01
Last updated
2026-09-01

Condition(s) studied

CancerRadiotherapy Side Effect

Study summary

Prospective cohort study of patients receiving standard-care radiotherapy is paramount to a better understanding of radiation effects and longterm outcomes.

The primary objective is to determine the feasibility of establishing infrastructure to systematically collect clinical data, patient-reported outcomes, and imaging data from daily radiotherapy practice.

Secondary objectives are to provide a control cohort for comparative effectiveness research of investigational interventions through a cmRCT design; compare imaging features with clinical outcomes; understand dose-effect relationships; quantify imaging quality metrics.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Ability to provide informed consent * Receiving radiotherapy or brachytherapy Exclusion Criteria: \-

Primary outcome measure(s)

Trial sites (9)

FacilityCityRegionStatus
BC Cancer - Kelowna Kelowna British Columbia Recruiting
BC Cancer - Vancouver Vancouver British Columbia Recruiting
London Health Regional Cancer Centre London Ontario Recruiting
Sunnybrook Research Institute Toronto Ontario Recruiting
Princess Margaret Cancer Centre Toronto Ontario Recruiting
CISSS de Laval - Hôpital de la Cité-de-la-Santé Laval Quebec Recruiting
Research Institute of the McGill University Health Center Montreal Quebec Recruiting
Centre Hospitalier de l'Université de Montréal Montreal Quebec Recruiting
CHU de Québec - Université Laval Québec Quebec Recruiting

More Centre hospitalier de l'Université de Montréal (CHUM) trials in Canada

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT03378856 on ClinicalTrials.gov ↗ ← All trials in Canada